Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07750821

Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD)

Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07750821.

📅 06 Aug 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07750821
Sponsor
Samantha Harrison
Start
2026-01-27
ClinicaliQ Trial Snapshot
  • Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07750821.
  • What is being tested: A co-designed balance training programme called Sport4Steadiness (S4S) delivered following pulmonary rehabilitation to assess its acceptability and feasibility in people with COPD, including evaluation of recruitment methods and outcome measurement procedures.
  • Patient eligibility overview: The trial focuses on people with COPD who have completed pulmonary rehabilitation; specific inclusion/exclusion criteria would determine enrolment based on disease severity, functional capacity, and ability to participate in balance training activities.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study aims to see if a co-designed balance training programme called Sport4Steadiness (S4S), is acceptable to people with COPD and if the study procedures, including recruitment and the collection of outcomes, is feasible.

Eligibility Snapshot
  • :
  • Adults with spirometry confirmed diagnosis of COPD as per GOLD guidelines (FEV1/FVC ratio below 0.7) or physician confirmed COPD diagnosis 2. Answers yes to one or more of the Three Key Questions* or Timed up and Go Test result > 11 seconds 3. An ability and capacity to provide consent to the trial * Q1. Have you fallen in the past year? Q2. Do you feel unsteady when standing or walking? Q3. Do you have worries about falling?

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘It’s not a nice world to bring children into’: Births fall to the lowest level in 50 years
Respiratory / COPD / Asthma · BBC Health · 27 May 2026
Record low fertility rates: Live births in England and Wales have fallen to their lowest level in 50 years, reflecting significant demographic…
View brief →
Guideline
UK Achondroplasia Network’s consensus guideline for multidisciplinary care of children and young people with achondroplasia: NICE review
Respiratory / COPD / Asthma · 19 May 2026
Establish multidisciplinary team review at diagnosis and at key developmental stages (infancy, pre-school, school age, adolescence) to monitor for complications including spinal…
View guideline →
Clinical Brief
There’s a reason child vaccination rates are falling – and it’s not social media
Respiratory / COPD / Asthma · BBC Health · 03 Aug 2026
Vaccination rates declining across UK: Child immunisation coverage is falling below safe thresholds needed for herd immunity, creating vulnerability to vaccine-preventable disease…
View brief →
Guideline
Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils
Respiratory / COPD / Asthma · 17 Jun 2026
Mepolizumab is recommended for patients with uncontrolled COPD and blood eosinophils ≥100 cells/μL; check eosinophil levels before initiating treatment as this is…
View guideline →
Clinical Brief
What is postpartum psychosis and why is it central in the Lindsay Clancy trial?
Respiratory / COPD / Asthma · BBC Health · 19 Aug 2026
Postpartum psychosis is a rare but severe psychiatric emergency occurring in 1-2 per 1,000 deliveries, characterised by delusions, hallucinations, and disorganised thinking…
View brief →
Clinical Brief
Why illegal children’s homes are being paid up to £2m per child by councils
Respiratory / COPD / Asthma · BBC Health · 20 May 2026
Councils are circumventing regulations by continuing to fund placements in unregistered children's homes despite legal prohibitions, creating significant safeguarding risks for vulnerable…
View brief →